Pharmaceuticals - Burundi

  • Burundi
  • The Pharmaceuticals market in Burundi is expected to witness a substantial increase in revenue, reaching US$23.65m in 2024.
  • Among the various markets, Oncology Drugs stands out as the largest, with a projected market volume of US$3.22m in the same year.
  • Furthermore, this sector is anticipated to experience a steady annual growth rate of 6.56% from 2024 to 2029 (CAGR 2024-2029), culminating in a market volume of US$32.50m by the end of the forecast period.
  • It is worth noting that, in terms of global comparison, United States is expected to generate the highest revenue of US$630.30bn in 2024.
  • Burundi's pharmaceutical market is experiencing growth due to increased government investment in healthcare infrastructure.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmaceuticals market in Burundi has experienced significant growth in recent years, driven by a variety of factors.

Customer preferences:
Burundian consumers have become increasingly health-conscious in recent years, leading to a greater demand for pharmaceutical products. Additionally, the country's growing population and rising income levels have contributed to increased demand for healthcare services, including pharmaceuticals.

Trends in the market:
One of the key trends in the Burundian pharmaceuticals market is the increasing availability of generic drugs. This has been driven by a number of factors, including the expiration of patents on several major drugs and the efforts of the government and international organizations to promote the use of generic drugs.Another trend in the market is the growing focus on preventive healthcare. This has led to increased demand for products such as vitamins, supplements, and other over-the-counter products that can help consumers maintain good health.

Local special circumstances:
One of the major challenges facing the Burundian pharmaceuticals market is the lack of adequate infrastructure and resources. This has made it difficult for pharmaceutical companies to distribute their products effectively, particularly in rural areas where access to healthcare services is limited.Another challenge is the high cost of healthcare services in the country, which has made it difficult for many consumers to access the products they need. This has led to a growing demand for affordable healthcare solutions, including generic drugs and other low-cost alternatives.

Underlying macroeconomic factors:
The Burundian pharmaceuticals market is influenced by a range of macroeconomic factors, including the country's political stability, economic growth, and investment climate. In recent years, the government has implemented a number of reforms aimed at improving the business environment and attracting foreign investment, which has helped to support the growth of the pharmaceuticals sector.Overall, the Burundian pharmaceuticals market is expected to continue to grow in the coming years, driven by a range of factors including changing consumer preferences, growing demand for generic drugs, and efforts to improve access to healthcare services. However, challenges such as the lack of adequate infrastructure and high healthcare costs will need to be addressed in order to ensure continued growth and development in the sector.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)